| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/10/2009 | US20090227512 Methods and compositions for treating and preventing distal bowel lesions |
| 09/10/2009 | US20090227511 Methods and compositions for treating lesions of the respiratory epithelium |
| 09/10/2009 | US20090227509 Modulation of hiv replication by rna interference |
| 09/10/2009 | US20090227501 Agents for preventing and/or treating upper digestive tract disorders |
| 09/10/2009 | US20090227500 Genes affecting human memory performance |
| 09/10/2009 | US20090227497 Variant activin receptor polypeptides and uses thereof |
| 09/10/2009 | US20090227493 Combined drug for treating diabetes |
| 09/10/2009 | US20090227489 STAT3 Agonists and Antagonists and Therapeutic Uses Thereof |
| 09/10/2009 | US20090226987 Desaturase Genes, Enzymes Encoded Thereby, and Uses Thereof |
| 09/10/2009 | US20090226936 Tetrahydrofolate Synthetase Gene |
| 09/10/2009 | US20090226551 Pharmaceutical composition for prevention and/or treatment of bone loss |
| 09/10/2009 | US20090226547 Dietary Supplement For Eye Health |
| 09/10/2009 | US20090226545 Anti-Glycation Methods and Compositions |
| 09/10/2009 | US20090226539 Treatment of Ovarian Cancer |
| 09/10/2009 | US20090226538 Anticancer or antiviral composition |
| 09/10/2009 | US20090226537 Mixtures comprising anthranilic acid amides and antidandruff agents as cosmetic and pharmaceutical compositions for alleviating itching |
| 09/10/2009 | US20090226531 Methods and composition for intraocular delivery of therapeutic sirna |
| 09/10/2009 | US20090226528 Encapsulated nanoparticles for nucleic acid delivery |
| 09/10/2009 | US20090226526 Nanoparticles of a heterocrystal mineral for use as a medicament and method of producing the same |
| 09/10/2009 | US20090226524 Stable active compound complex of salts of o-acetylsalicylic acid with basic amino acids and glycine |
| 09/10/2009 | US20090226522 Process to minimize polymorphism |
| 09/10/2009 | US20090226521 Active nanoparticles and method of using |
| 09/10/2009 | US20090226520 Medical composition employing nanostructures |
| 09/10/2009 | US20090226518 (monitoring only) combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hypelipidemia once a day at night |
| 09/10/2009 | US20090226516 Sartan compositions |
| 09/10/2009 | US20090226515 Statin compositions |
| 09/10/2009 | US20090226514 Compressed |
| 09/10/2009 | US20090226513 Na/K-ATpase Ligand |
| 09/10/2009 | US20090226512 Methods and Compositions for Oral Delivery of FTS |
| 09/10/2009 | US20090226511 Novel pharmaceutical formulation in the form of cellulose capsules suitable for benzimidazole derivatives |
| 09/10/2009 | US20090226510 Pharmaceutical compositions of atorvastatin |
| 09/10/2009 | US20090226509 Composition for treatment of inflammatory disorders |
| 09/10/2009 | US20090226507 Hydroxide-releasing agents as skin permeation enhancers |
| 09/10/2009 | US20090226505 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/10/2009 | US20090226503 Adhesion inhibiting material for vertebral/spinal operation |
| 09/10/2009 | US20090226500 Sutures and anti-scarring agents |
| 09/10/2009 | US20090226498 Moisturizing hand sanitizer |
| 09/10/2009 | US20090226494 Pathogen - controlling products |
| 09/10/2009 | US20090226481 Compositions Ameliorating a Reduced Diurnal Activity and/or Depressive Symptoms |
| 09/10/2009 | US20090226467 De novo synthesis of bacteriochlorins |
| 09/10/2009 | US20090226463 Novel method of modulating bone-related activity |
| 09/10/2009 | US20090226462 use of polypeptide in a vaccine for protection of fish from Aeromomas |
| 09/10/2009 | US20090226460 Compositions and methods for the treatment of disease |
| 09/10/2009 | US20090226456 screening methods for identifying agonists and antagonists of TNFR-6 alpha & -6 beta activity; diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders; cancer |
| 09/10/2009 | US20090226451 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 09/10/2009 | US20090226450 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 09/10/2009 | US20090226449 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226448 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226446 Method to Inhibit the Propagation of an Undesired Cell Population |
| 09/10/2009 | US20090226444 Pharmaceutical antibody compositions with resistance to soluble cea |
| 09/10/2009 | US20090226443 Combination therapy with c-met and egfr antagonists |
| 09/10/2009 | US20090226432 Pharmaceutical compositions with resistance to soluble cea |
| 09/10/2009 | US20090226431 Treatment of Cancer and Other Diseases |
| 09/10/2009 | US20090226430 Recombinant anti-cd4 antibodies for human therapy |
| 09/10/2009 | US20090226427 Novel pharmaceutical compositions for modulating angiogenesis |
| 09/10/2009 | US20090226425 Diagnostics and Therapeutics For Glaucoma |
| 09/10/2009 | US20090226424 Subdermal tissue remodeling using myostatin, methods and related systems |
| 09/10/2009 | US20090226423 Protein kinase C as a target for the treatment of respiratory syncytial virus |
| 09/10/2009 | US20090226422 Chemical Inhibitors of Inhibitors of Differentiation |
| 09/10/2009 | US20090226412 Agent for reduction of bleeding in cerebrovascular disorder |
| 09/10/2009 | US20090226411 Chemical derivatives and their application as antitelomerase agents |
| 09/10/2009 | US20090226408 Anti-fatigue composition |
| 09/10/2009 | US20090226407 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 09/10/2009 | US20090226405 COMPOSITIONS AND METHODS TO TREAT CANCER WITH CUPREDOXINS AND CpG RICH DNA |
| 09/10/2009 | US20090226403 Olfactory and pheromones G-protein coupled receptors |
| 09/10/2009 | US20090226401 Methods and compositions for the treatment of parkinson's disease |
| 09/10/2009 | US20090226400 Continuous delivery methods for treating hepatitis virus infection |
| 09/10/2009 | US20090226398 Anti-viral compounds, compositions, and methods of use |
| 09/10/2009 | US20090226395 Pharmaceutical compositions of beta-lapachone and beta-lapachone analogs with improved tumor targeting potential |
| 09/10/2009 | US20090226393 Polymer paclitaxel conjugates and methods for treating cancer |
| 09/10/2009 | US20090226392 Phosphate-Binding Polymers for Oral Administration |
| 09/10/2009 | US20090226391 Hemostatic Sponge and Method of Manufacture |
| 09/10/2009 | US20090226380 Topical Skin Treating Compositions |
| 09/10/2009 | US20090226379 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/10/2009 | US20090226377 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors |
| 09/10/2009 | US20090226375 MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION AND USES THEREOF |
| 09/10/2009 | US20090226368 Androgen-Receptor (AR) Ligands for Use in the Treatment and Diagnosis of AR-Related Pathologies |
| 09/10/2009 | DE20321763U1 Synergistisch wirkende Kombination von Phenylbutyrat und Aminobenzoesäure zur Krebstherapie Synergistic combination of phenylbutyrate and aminobenzoic acid for cancer therapy |
| 09/10/2009 | DE202009007345U1 Neue Pharmazeutika und Arzneimittelzubereitungen New pharmaceuticals and pharmaceutical preparations |
| 09/10/2009 | DE102009011742A1 Aqueous liquid formulation, useful for treating migraine, comprises phospholipids, coenzyme Q10, blueberry extract (extract of Vaccinium myrtillus), and polyol comprising e.g. aldose, ketose, reduced aldose and/or ketose |
| 09/10/2009 | DE102008012988A1 Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums Composition and uses for affecting hair growth |
| 09/10/2009 | DE102008012909A1 Verwendung von Flavonoidverbindungen für die Prophylaxe und Therapie ischämischer oder entzündlicher Herz- und Kreislauferkrankungen Use of flavonoid compounds for the prophylaxis and treatment of ischemic or inflammatory cardiovascular diseases |
| 09/10/2009 | DE102008011692A1 Wirkstoffkombination und deren Verwendung Combination of active substances and their use |
| 09/09/2009 | EP2098595A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 09/09/2009 | EP2098593A1 hTERT expression regulatory gene |
| 09/09/2009 | EP2098534A1 Esters of glucuronide prodrugs of anthracyclines and method of preparation and use in tumor-selective chemotherapy |
| 09/09/2009 | EP2098533A1 Esters of glucuronide prodrugs of anthracyclines and method of preparation and use in tumor-selective chemotherapy |
| 09/09/2009 | EP2098526A1 Nitrogen-containing bicyclic compounds active on chronic pain conditions |
| 09/09/2009 | EP2098525A1 Crystalline carbapenem compound and produced method thereof |
| 09/09/2009 | EP2098521A1 Crystal forms of N-[2-(diethylamino) ethyl]-5-[fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrolle-3-carboxamide and methods for their prepparation |
| 09/09/2009 | EP2098519A1 Process for the synthesis of ramelteon and its intermediates |
| 09/09/2009 | EP2098517A1 Novel phenyl-isoxazol-3-ol derivative |
| 09/09/2009 | EP2098515A1 Substituted carbinol compound |
| 09/09/2009 | EP2098514A1 Preparation of compounds useful for the detection of hypoxia |
| 09/09/2009 | EP2098513A1 Tricyclic compound and pharmaceutical use thereof |
| 09/09/2009 | EP2098512A1 Compounds and methods for treating dyslipidemia |
| 09/09/2009 | EP2098509A1 1-naphthyl alkylpiperidine derivative |
| 09/09/2009 | EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/09/2009 | EP2098507A1 Cyclic amine compound |
| 09/09/2009 | EP2098503A1 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide |